RxDoctor Payments Data

Denna Watson, PA

Medical · New Albany, INNPI 1083655690

Payments from drug & device makers

$1,164in general payments, 2019–2025

Across 96 payments — averaging $12.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$329
  • Sunovion Pharmaceuticals Inc.$138
  • Johnson & Johnson$126
  • Vanda Pharmaceuticals Inc.$123
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$113
  • Lundbeck LLC$82
  • plus $253 from 7 others

What the payments were for

  • Food & beverage$1,11796%
  • Education$474%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,164 in reported general payments places this provider in the 70th percentile of 273 medical providers in Indiana.

See all medical providers in Indiana

Medicare billing

Part B allowed, 2024
$18,412
Medicare patients
58
Services billed
217

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine22$119,915
VraylarCariprazine Hcl54$92,305
TrintellixVortioxetine Hydrobromide64$42,150
Invega SustennaPaliperidone Palmitate12$41,277
Lurasidone Hcl52$19,893
Aripiprazole89$18,639
CaplytaLumateperone Tosylate11$18,144
Desvenlafaxine Succinate ErDesvenlafaxine Succinate110$16,311
Vilazodone Hcl80$11,155
QuviviqDaridorexant Hcl15$7,289
Quetiapine Fumarate194$5,643
VyvanseLisdexamfetamine Dimesylate14$5,424
Divalproex Sodium ErDivalproex Sodium44$4,746
Asenapine Maleate16$4,439
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine130$3,934

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$329$92,30554 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$52$47,57378 claims
Johnson & JohnsonInvega Sustenna$126$41,27712 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$113$18,14411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 273 medical providers in Indiana.

Other medical in New Albany

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →